Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11655285 Human immunodeficiency virus neutralizing antibodies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Gilead Sciences
Gilead Sciences
0
Date Filed
December 3, 2020
0
Date of Patent
May 23, 2023
0
Patent Applicant
Gilead Sciences
Gilead Sciences
0
Patent Application Number
17110876
0
Patent Citations
‌
US Patent 8394925 Fc variants with altered binding to FcRn
0
‌
US Patent 8546543 Fc variants that extend antibody half-life
0
‌
US Patent 8840890 Rapid expression cloning of human monoclonal antibodies from memory B cells
0
‌
US Patent 8937158 Fc variants with increased affinity for FcγRIIc
0
‌
US Patent 9040041 Modified FC molecules
0
‌
US Patent 9353187 Optimized FC variants and methods for their generation
0
‌
US Patent 9464131 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
0
‌
US Patent 9803023 Fc variants with altered binding to FcRn
0
‌
US Patent 10087239 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
0
‌
US Patent 10184000 Optimized Fc variants and methods for their generation
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11655285
0
Patent Primary Examiner
‌
Nicole Kinsey White
0

Find more entities like US Patent 11655285 Human immunodeficiency virus neutralizing antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.